Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Group 3: Traditional product 2 capsules in the morning and 2 nights during the month, except during the period plus metformin 500 mg tablets after every meal during month. Intervention
Treatment - Drugs
Group 3: Traditional product 2 capsules in the morning and 2 nights during the month, except during the period plus metformin 500 mg tablets after every meal during month.
Group 2: Metformin 500 mg tablets after every meal during month
Group 1: Traditional medicine product 2 capsules in the morning and 2 nights during the month, except during the period
Sponsors
School of Traditional Medicine and Materia Medica Research Center Shahid Beheshti
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with PCOS their main complaint is oligomenorrhea. Age 40-18 years, patient satisfaction, the absence of any systemic disease such as hyperinsulinemia, hyperandrogenism, diabetes mellitus, Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia and hyperthyroidism, hypertension, lack of pregnancy or within 6 weeks post-partum, lack of breastfeeding, non-hormonal drugs in the last month, no family history of breast and ovarian cancer. Exclusion criteria: Hormone therapy use, side effects, the need for other interventions and surgery, pregnancy occurred during the study, the patient's own request for exclusion.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Experience of menstural bleeding. Timepoint: Before intervention and 3, 4 month after intervention. Method of measurement: Question from patient.;Duration of bleeding. Timepoint: Before the intervention, month 3, 4. Method of measurement: Ask the patient.;Menstrual blood volume. Timepoint: Before the intervention, month 3,4. Method of measurement: Pictorial Blood Loss Assessment Chart (PBAC). | — |
Secondary
| Measure | Time frame |
|---|---|
| Added at 2016-07-02: interval between menstural periods. Timepoint: Added at 2016-07-02: Before the intervention and 1, 2, and 3 months after the intervention. Method of measurement: Added at 2016-07-02: Asking from patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Bahman
School of Traditional Medicine Traditional Medicine and Materia Medica Research Center Shahid Behesh
Outcome results
None listed